Inhibition of focal adhesion kinase induces apoptosis in bladder cancer cells via Src and the phosphatidylinositol 3-kinase/Akt pathway

Kong,Debo; Chen,Feng; Sima,Ni

doi:10.3892/etm.2015.2745

Inhibition of focal adhesion kinase induces apoptosis in bladder cancer cells via Src and the phosphatidylinositol 3-kinase/Akt pathway

Authors:
- Debo Kong
- Feng Chen
- Ni Sima
View Affiliations

Affiliations: Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Surgery, The Jiujiang Traditional Chinese Medicine Hospital, Jiujiang, Jiangxi 332000, P.R. China, Department of Gynecologic Oncology, Women's Reproductive Health Key Laboratory of Zhejiang, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
Published online on: September 11, 2015 https://doi.org/10.3892/etm.2015.2745
Pages: 1725-1731
Copyright: © Kong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Focal adhesion kinase (FAK) is a 125-kDa, cytosolic, non-receptor, protein tyrosine kinase localized at focal adhesions that can be activated by multiple inputs and in different manners. FAK is implicated in signaling pathways regulating cell movement, invasion, survival, gene expression and cancer stem cell self‑renewal. The aim of the present study was to investigate whether FAK plays a role in the apoptosis of bladder cancer cells. The study employed in situ deoxynucleotidyl transferase‑mediated dUTP‑biotin nick end labeling and Annexin V labeling flow cytometry. It was found that both the knockdown of FAK and the suppression of FAK phosphorylation were able to induce apoptosis in bladder cancer cells. Caspase‑3 was activated during the apoptosis induced by the suppression of FAK phosphorylation. Src was involved in FAK‑regulated apoptosis in bladder cancer cells, while the suppression of Src phosphorylation was able to inhibit FAK tyrosine phosphorylation and induce apoptosis. Furthermore, phosphatidylinositol 3‑kinase (PI3K)/Akt signaling was inhibited via the suppression of FAK tyrosine phosphorylation. Conversely, the expression of neither the general nor the tyrosine‑phosphorylated FAK was regulated by inhibiting PI3K/Akt, which suggested that PI3K/Akt acted downstream of FAK to regulate apoptosis in bladder cancer cells. These findings indicate the presence of a mechanism of apoptosis involving FAK‑mediated oncogenic signaling. FAK may function as an important regulator of extracellular signaling‑mediated apoptosis in bladder cancer and be used as a novel therapeutic target in the treatment of the condition.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Morgan TM, Keegan KA and Clark PE: Bladder cancer. Curr Opin Oncol. 23:275–282. 2011. View Article : Google Scholar : PubMed/NCBI
3	van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA and Zlotta AR: Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy. Eur Urol. 56:430–442. 2009. View Article : Google Scholar : PubMed/NCBI
4	Lee CT, Dunn RL, Ingold C, Montie JE and Wood DP Jr: Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion. Urology. 69:1068–1072. 2007. View Article : Google Scholar : PubMed/NCBI
5	Prout GR Jr, Griffin PP and Shipley WU: Bladder carcinoma as a systemic disease. Cancer. 43:2532–2539. 1979. View Article : Google Scholar : PubMed/NCBI
6	Parsons JT: Focal adhesion kinase: The first ten years. J Cell Sci. 116:1409–1416. 2003. View Article : Google Scholar : PubMed/NCBI
7	Lechertier T and Hodivala-Dilke K: Focal adhesion kinase and tumour angiogenesis. J Pathol. 226:404–412. 2012. View Article : Google Scholar : PubMed/NCBI
8	Okamoto H, Yasui K, Zhao C, Arii S and Inazawa J: PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology. 38:1242–1249. 2003. View Article : Google Scholar : PubMed/NCBI
9	Park JH, Lee BL, Yoon J, Kim J, Kim MA, Yang HK and Kim WH: Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer. Hum Pathol. 41:1664–1673. 2010. View Article : Google Scholar : PubMed/NCBI
10	Sulzmaier FJ, Jean C and Schlaepfer DD: FAK in cancer: Mechanistic findings and clinical applications. Nat Rev Cancer. 14:598–610. 2014. View Article : Google Scholar : PubMed/NCBI
11	Oktay MH, Oktay K, Hamele-Bena D, Buyuk A and Koss LG: Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol. 34:240–245. 2003. View Article : Google Scholar : PubMed/NCBI
12	Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature. 474:609–615. 2011. View Article : Google Scholar : PubMed/NCBI
13	Cancer Genome Atlas N Network: Comprehensive molecular portraits of human breast tumours. Nature. 490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
14	Lu H, Wang L, Gao W, Meng J, Dai B, Wu S, Minna J, Roth JA, Hofstetter WL, Swisher SG and Fang B: IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells. Mol Cancer Ther. 12:2864–2873. 2013. View Article : Google Scholar : PubMed/NCBI
15	Schober M and Fuchs E: Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling. Proc Natl Acad Sci USA. 108:10544–10549. 2011. View Article : Google Scholar : PubMed/NCBI
16	Wendt MK, Smith JA and Schiemann WP: Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene. 29:6485–6498. 2010. View Article : Google Scholar : PubMed/NCBI
17	Luo M and Guan JL: Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett. 289:127–139. 2010. View Article : Google Scholar : PubMed/NCBI
18	Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S and Ma D: RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Apoptosis. 13:273–281. 2008. View Article : Google Scholar : PubMed/NCBI
19	Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, Lu WG and Xie X: Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer. 47:2166–2174. 2011. View Article : Google Scholar : PubMed/NCBI
20	Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, et al: Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Gynecol Oncol. 106:299–304. 2007. View Article : Google Scholar : PubMed/NCBI
21	Guan JL and Shalloway D: Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature. 358:63881992. View Article : Google Scholar
22	Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
23	Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E and Kasahara T: FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem. 274:10566–10570. 1999. View Article : Google Scholar : PubMed/NCBI
24	Linder ME and Burr JG: Nonmyristoylated p60v-src fails to phosphorylate proteins of 115–120 kDa in chicken embryo fibroblasts. Proc Natl Acad Sci USA. 85:2608–2612. 1988. View Article : Google Scholar : PubMed/NCBI
25	Reynolds AB, Roesel DJ, Kanner SB and Parsons JT: Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol. 9:629–638. 1989.PubMed/NCBI
26	Kanner SB, Reynolds AB, Vines RR and Parsons JT: Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA. 87:3328–3332. 1990. View Article : Google Scholar : PubMed/NCBI
27	Guan JL, Trevithick JE and Hynes RO: Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul. 2:951–964. 1991.PubMed/NCBI
28	Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB and Parsons JT: pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA. 89:5192–5196. 1992. View Article : Google Scholar : PubMed/NCBI
29	Hanks SK, Calalb MB, Harper MC and Patel SK: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA. 89:8487–8491. 1992. View Article : Google Scholar : PubMed/NCBI
30	Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR and Parsons JT: Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol. 14:1680–1688. 1994.PubMed/NCBI
31	Park MS, Kim YH and Lee JW: FAK mediates signal crosstalk between type II collagen and TGF-beta 1 cascades in chondrocytic cells. Matrix Biol. 29:135–142. 2010. View Article : Google Scholar : PubMed/NCBI
32	Duvall E, Wyllie AH and Morris RG: Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology. 56:351–358. 1985.PubMed/NCBI
33	Frisch SM, Vuori K, Ruoslahti E and Chan-Hui PY: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 134:793–799. 1996. View Article : Google Scholar : PubMed/NCBI
34	Sonoda Y, Kasahara T, Yokota-Aizu E, Ueno M and Watanabe S: A suppressive role of p125FAK protein tyrosine kinase in hydrogen peroxide-induced apoptosis of T98G cells. Biochem Biophys Res Commun. 241:769–774. 1997. View Article : Google Scholar : PubMed/NCBI
35	Clemente CF, Tornatore TF, Theizen TH, Deckmann AC, Pereira TC, Lopes-Cendes I, Souza JR and Franchini KG: Targeting focal adhesion kinase with small interfering RNA prevents and reverses load-induced cardiac hypertrophy in mice. Circ Res. 101:1339–1348. 2007. View Article : Google Scholar : PubMed/NCBI
36	Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW and Whang EE: RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem Biophys Res Commun. 311:786–792. 2003. View Article : Google Scholar : PubMed/NCBI
37	Chan KT, Cortesio CL and Huttenlocher A: FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol. 185:357–370. 2009. View Article : Google Scholar : PubMed/NCBI
38	Thamilselvan V, Craig DH and Basson MD: FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J. 21:1730–1741. 2007. View Article : Google Scholar : PubMed/NCBI
39	Shi Q, Bao S, Song L, Wu Q, Bigner DD, Hjelmeland AB and Rich JN: Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene. 26:4084–4094. 2007. View Article : Google Scholar : PubMed/NCBI
40	Leask A: Focal adhesion kinase: A key mediator of transforming growth factor beta signaling in fibroblasts. Adv Wound Care (New Rochelle). 2:247–249. 2013. View Article : Google Scholar : PubMed/NCBI
41	Wang SE, Xiang B, Zent R, Quaranta V, Pozzi A and Arteaga CL: Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Res. 69:475–482. 2009. View Article : Google Scholar : PubMed/NCBI
42	Schaller MD: Cellular functions of FAK kinases: Insight into molecular mechanisms and novel functions. J Cell Sci. 123:1007–1013. 2010. View Article : Google Scholar : PubMed/NCBI
43	Mitra SK and Schlaepfer DD: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
44	Chiang GJ, Billmeyer BR, Canes D, Stoffel J, Moinzadeh A, Austin CA, Kosakowski M, Rieger-Christ KM, Libertino JA and Summerhayes IC: The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt. BJU Int. 96:416–422. 2005. View Article : Google Scholar : PubMed/NCBI
45	Wen LP, Fahrni JA, Troie S, Guan JL, Orth K and Rosen GD: Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem. 272:26056–26061. 1997. View Article : Google Scholar : PubMed/NCBI
46	Levkau B, Herren B, Koyama H, Ross R and Raines EW: Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med. 187:579–586. 1998. View Article : Google Scholar : PubMed/NCBI
47	van de Water B, Nagelkerke JF and Stevens JL: Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells. J Biol Chem. 274:13328–13337. 1999. View Article : Google Scholar : PubMed/NCBI
48	Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK and Kasahara T: Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J Biol Chem. 275:16309–16315. 2000. View Article : Google Scholar : PubMed/NCBI